SMO and Hepatic fibrosis: This study provides evidence that plant-derived miR-55, delivered via a gatrointestinally stable and patented oral system, exerts its potent anti-fibrotic effect through a mechanism associated with disruption of the CK2α/SMO protein–protein interaction, leading to the significant reversal of MAFLD-related liver fibrosis.